Skip to content

Rx-Mastery

Menu
  • [投資まとめ]
Menu

Eli Lilly – Financials

売上高純利益1株益Q/Q
2024Q211,3022,9673.2836%
2024Q18,7682,2422.4826%
2023Q49,3532,1902.4228%
2023Q39,499-57-0.0637%
2023Q28,3121,7631.9528%
2023Q16,9601,3451.49-11%
2022Q47,3021,9382.14-9%
2022Q36,9421,4521.612%
2022Q26,4889531.05-4%
2022Q17,8101,9032.1015%
2021Q48,0001,7261.888%
2021Q36,7731,1101.2218%
2021Q26,7401,3901.5323%
2021Q16,8061,3551.4916%
2020Q47,4402,1172.3122%
2020Q35,7411,2081.335%
2020Q25,4991,4121.55-2%
2020Q15,8601,4571.6015%
2019Q46,1141,4961.778%
2019Q35,4771,2541.373%
2019Q25,6371,3271.441%
2019Q15,0924,2424.313%
2018Q45,6381,1251.1073%
2018Q35,3071,1501.12-6%
2018Q25,585-260-0.25-4%
2018Q14,9641,2171.16-5%
2017Q43,263-1,657-1.57-43%
2017Q35,6585560.539%
2017Q25,8241,0080.958%
2017Q15,228-111-0.107%
2016Q45,7617720.737%
2016Q35,1927780.735%
2016Q25,4057480.719%
2016Q14,8654400.415%
2015Q45,3764780.455%
2015Q34,9608000.752%
2015Q24,9796010.561%
2015Q14,6455300.50-1%
2014Q45,1214290.40-12%
2014Q34,8765010.47-16%
2014Q24,9367340.68-17%
2014Q14,6837280.68-16%
2013Q45,8097280.68-2%
2013Q35,7731,2031.116%
2013Q25,9301,2061.116%
2013Q15,6021,5481.420%
2012Q45,9578270.74-1%
2012Q35,4431,3271.18-11%
2012Q25,6019240.83-10%
2012Q15,6021,0110.91-4%
2011Q46,0478580.77-2%
2011Q36,1481,2361.119%
2011Q26,2531,1971.079%
2011Q15,8391,0560.956%
2010Q46,1871,1701.054%
2010Q35,6551,3031.182%
2010Q25,7491,3491.229%
2010Q15,4861,2481.139%

Categories

  • クスリ
  • 写真
  • 投資
© 2025 Rx-Mastery | Powered by Minimalist Blog WordPress Theme